Skip to search boxSkip to navigationSkip to main content

Lead acetate-induced contraction in rabbit mesenteric artery: Interaction with calcium and protein kinase C

  • Stephanie W. Watts(corresponding author)
    ,
  • Siangshu Chai
    ,
  • R. Clinton Webb
*Corresponding author for this work
  • University of Michigan, Ann Arbor
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Animal studies have demonstrated that low-level lead exposure produces hypertension and that lead can cause contraction of vascular smooth muscle directly. The physiological effects of lead have been associated with both stimulation and inhibition of protein kinase C (PKC). Given that vascular smooth muscle contractility is generally enhanced when protein kinase C is activated, we have tested the hypothesis that lead contracts vascular smooth muscle via stimulation of PKC. Helically-cut strips of rabbit mesenteric artery were mounted in muscle baths for measurement of isometric force development. Cumulative addition of lead acetate (10-10-10-3 M) to the muscle bath produced contractions (concentration necessary to produce half-maximal response -log EC50 = 5.16 ± 0.07). Maximal contraction to lead acetate in arteries denuded of endothelium did not differ from those in intact vessels, supporting the hypothesis that lead-induced contraction is an endothelium-independent event. Contractions to lead acetate were potentiated by the PKC activators, phorbol 12-myristate 13-acetate (TPA; 3 × 10-7 M) and mezerein (3 × 10-7 M), as indicated by leftward shifts in the concentration-response curve and increase in the potency of lead (-log EC50 with TPA: 6.94 ± 0.07; -log EC50 with mezerein: 6.07 ± 0.04). H-7 (6 × 10-6 M), an inhibitor of PKC, decreased maximal contraction to lead ~65% and slightly, but insignificantly, decreased the potency of lead (-log EC50 = 4.82 ± 0.1). The inactive phorbol ester, phorbol 12-myristate 13-acetate 4-0-methyl ether (1 × 10-6 M), did not alter contractile responses to lead (-log EC50 = 4.92 ± 0.09). Vascular contraction to lead partially depends on extracellular calcium as the L-type voltage-gated calcium channel antagonist, verapamil (3 × 10-6 M), decreased leadinduced contractions by 50%. These data indicate that lead interacts with PKC in an endothelium-independent, calcium-dependent manner to cause vascular smooth muscle contraction and suggest that lead-induced increases in vascular contractility may play a role in lead-induced hypertension.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 55-65 (11 pages)

Journal (Volume, Issue Number)

Toxicology (Volume 99, Issue 1-2)

Publication milestones

  • Published - 05/05/1995

Publication status

Published - 05/05/1995

ISSN

0300-483X

Publication IDs

  • Scopus: 0029007474
  • PubMed: 7762002

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
63
Captures
11

Funding Details

FunderFunding number
NHLBI
P01HL018575